Nuvalent Inc vs Vanguard Growth Index Fund ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Vanguard Growth Index Fund ETF trades at $86.16. The key difference: Nuvalent Inc is trading nearer its 52-week high, Vanguard Growth Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | VUG | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $123.96 | $90.29 |
52-Week Low | $72.16 | $70.00 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →